⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15949959 | 0.97 | — | — | |
| Ethane SCHEMBL9622750 | 0.94 | FFAR3 (0.37) | — | |
| SCHEMBL7042942 | 0.80 | HMGCR (0.32) | — | |
| SCHEMBL7046233 | 0.76 | FFAR3 (0.31) | — | |
| SCHEMBL3078982 | 0.69 | LMNA (0.40) | — | |
| SCHEMBL708170 | 0.69 | — | — | |
| SCHEMBL8914380 | 0.67 | — | — | |
| SCHEMBL379201 | 0.67 | — | — | |
| SCHEMBL838161 | 0.64 | — | — | |
| SCHEMBL3590719 | 0.64 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024253189-A1 | PROPHYLACTIC AND/OR AMELIORATING AGENT FOR PERIPHERAL NEUROPATHY CAUSED BY CANCER CHEMOTHERAPEUTIC AGENT | 国立大学法人 富山大学 | 2024-12-12 | — | — | WO | claimed |
| CN-116997335-A | Preventive or therapeutic agent for side effects of anthracycline anticancer agent | 国立大学法人九州大学 | 2023-11-03 | — | — | CN | claimed |
| CN-109689038-B | Aqueous preparation containing 5-aminoacetopropionic acids | 思佰益药业股份有限公司 | 2022-05-13 | — | — | CN | claimed |
| EP-2456424-B1 | OXIDATION-STABILIZED TAMPER-RESISTANT DOSAGE FORM | GRUENENTHAL GMBH (DE) | 2013-08-28 | — | — | EP | claimed |
| US-12467053-B2 | Hybrid immunoglobulins with moving parts | BIOMOLECULAR HOLDINGS LLC (US) | 2025-11-11 | — | — | US | disclosed |
| CN-118829426-A | Pharmaceutical composition for preventing and/or treating autoimmune diseases | 国立研究开发法人国立成育医疗研究中心 | 2024-10-22 | — | — | CN | disclosed |
| CN-116997335-A | Preventive or therapeutic agent for side effects of anthracycline anticancer agent | 国立大学法人九州大学 | 2023-11-03 | — | — | CN | disclosed |
| WO-2023167066-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING AND/OR TREATING AUTOIMMUNE DISEASES | 国立研究開発法人国立成育医療研究センター | 2023-09-07 | — | — | WO | disclosed |
| WO-2022202477-A1 | PROPHYLACTIC AGENT OR THERAPEUTIC AGENT FOR SIDE EFFECTS OF ANTHRACYCLINE ANTICANCER AGENT | 国立大学法人九州大学 | 2022-09-29 | — | — | WO | disclosed |
| US-20210289794-A1 | COMPOSITIONS AND RELATED METHODS FOR AGRICULTURE | FLAGSHIP PIONEERING INNOVATIONS V, INC. | 2021-09-23 | — | — | US | disclosed |
| EP-3284825-B1 | METHODS OF PRODUCING HYBRID POLYPEPTIDES WITH MOVING PARTS | BIOMOLECULAR HOLDINGS LLC (US) | 2021-04-07 | — | — | EP | disclosed |
| US-20200032272-A1 | HYBRID IMMUNOGLOBULINS WITH MOVING PARTS | BIOMOLECULAR HOLDINGS LLC | 2020-01-30 | — | — | US | disclosed |
| US-7906763-B2 | Multiband infrared imaging device | MENGEL ARTHUR H | 2011-03-15 | — | — | US | disclosed |
| US-20100025583-A1 | Multiband infrared imaging device | MENGEL ARTHUR H | 2010-02-04 | — | — | US | disclosed |
| WO-2008140477-A9 | HYBRID IMMUNOGLOBULINS WITH MOVING PARTS | CAPON DANIEL J (US) | 2009-10-15 | — | — | WO | disclosed |
| EP-2078040-A2 | HYBRID IMMUNOGLOBULINS WITH MOVING PARTS | Capon, Daniel J. (US) | 2009-07-15 | — | — | EP | disclosed |
| WO-2008140477-A2 | HYBRID IMMUNOGLOBULINS WITH MOVING PARTS | CAPON DANIEL J (US) | 2008-11-20 | — | — | WO | disclosed |
| US-20080254512-A1 | Hybrid immunoglobulins with moving parts | BIOMOLECULAR HOLDINGS LLC | 2008-10-16 | — | — | US | disclosed |
| CN-1166561-C | synthesis of ferric boracate chloride | 中国科学院金属研究所 | 2004-09-15 | — | — | CN | disclosed |
| CN-1361059-A | synthesis of ferric boracate chloride | INST OF METALS ACADEMIA SINICA (CN) | 2002-07-31 | — | — | CN | disclosed |